HK1114883A1 - Skin aging marker and technique for use thereof - Google Patents

Skin aging marker and technique for use thereof

Info

Publication number
HK1114883A1
HK1114883A1 HK08110309.7A HK08110309A HK1114883A1 HK 1114883 A1 HK1114883 A1 HK 1114883A1 HK 08110309 A HK08110309 A HK 08110309A HK 1114883 A1 HK1114883 A1 HK 1114883A1
Authority
HK
Hong Kong
Prior art keywords
skin
skin aging
technique
aging
present
Prior art date
Application number
HK08110309.7A
Other languages
English (en)
Inventor
Satoshi Miyata
Kaoru Miyazaki
Chie Yasuda
Akihiro Iwamatsu
Original Assignee
Fancl Corp
Kaoru Miyazaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fancl Corp, Kaoru Miyazaki filed Critical Fancl Corp
Publication of HK1114883A1 publication Critical patent/HK1114883A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
HK08110309.7A 2005-08-23 2008-09-17 Skin aging marker and technique for use thereof HK1114883A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005240820 2005-08-23
PCT/JP2006/316407 WO2007023808A1 (ja) 2005-08-23 2006-08-22 皮膚老化マーカーとその利用技術

Publications (1)

Publication Number Publication Date
HK1114883A1 true HK1114883A1 (en) 2008-11-14

Family

ID=37771551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110309.7A HK1114883A1 (en) 2005-08-23 2008-09-17 Skin aging marker and technique for use thereof

Country Status (6)

Country Link
US (1) US7972788B2 (ja)
JP (4) JP5362219B2 (ja)
KR (1) KR101318521B1 (ja)
CN (1) CN101248192B (ja)
HK (1) HK1114883A1 (ja)
WO (1) WO2007023808A1 (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101318521B1 (ko) * 2005-08-23 2013-10-16 가오루 미야자키 피부 노화 마커와 그의 이용기술
JP5027528B2 (ja) * 2006-03-02 2012-09-19 株式会社ファンケル 皮膚老化の検査方法
JP5311439B2 (ja) * 2006-12-27 2013-10-09 日本メナード化粧品株式会社 皮膚の状態を評価する方法及びその用途
JP4971055B2 (ja) * 2007-06-29 2012-07-11 株式会社ファンケル 皮膚色素沈着マーカーとその利用技術
JP2009244154A (ja) * 2008-03-31 2009-10-22 Nationa Hospital Organization 老化、および血管障害を伴う疾患の検定のための組成物、キットおよび方法
FR2929517A1 (fr) * 2008-04-04 2009-10-09 Oreal Utilisation cosmetique de proteines de type annexine ii pour le traitement de la secheresse cutanee
FR2929518B1 (fr) * 2008-04-04 2013-06-28 Oreal Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane
JP2009276336A (ja) * 2008-04-14 2009-11-26 Kao Corp 毛穴目立ち予防又は改善剤評価方法
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
KR101612906B1 (ko) 2008-07-23 2016-04-19 한국과학기술원 피부에 가한 역학 자극의 스크리닝 방법
WO2010025341A2 (en) * 2008-08-28 2010-03-04 Dermtech International Determining age ranges of skin samples
KR100964433B1 (ko) * 2008-11-07 2010-06-16 (주)아모레퍼시픽 피부 기능 향상 물질의 스크리닝 방법
JP2010115131A (ja) * 2008-11-12 2010-05-27 Kao Corp 肌評価方法及び皮膚老化改善剤・皮膚老化予防剤のスクリーニング方法
JP4446009B1 (ja) * 2008-12-24 2010-04-07 株式会社ファンケル シワ形成リスク評価方法
JP4473926B1 (ja) * 2008-12-24 2010-06-02 株式会社ファンケル 紫外線による皮膚黒化傾向の評価方法
KR101098940B1 (ko) 2009-04-06 2011-12-28 대한민국 발암물질에 대한 바이오마커로서 moesin
EP2302381A1 (en) * 2009-06-30 2011-03-30 Ruprecht-Karls-Universität Heidelberg Gene signature for replicative senescence in cell cultures
JP5292341B2 (ja) * 2010-03-10 2013-09-18 株式会社ファンケル 皮膚角質層のタンパク質測定方法
ES2882325T3 (es) 2010-04-06 2021-12-01 Fertility Lab Sciences Llc Fecundación in vitro facilitada por el perfil de secretoma
WO2012008747A2 (ko) * 2010-07-13 2012-01-19 (주)아모레퍼시픽 피부 진단 방법 및 키트
CN102465182A (zh) * 2010-10-29 2012-05-23 株式会社爱茉莉太平洋 检测皮肤活性物质的检测试剂盒和检测皮肤活性物质的方法
KR101886342B1 (ko) * 2010-11-30 2018-08-10 (주)아모레퍼시픽 피부 노화와 관련된 유전자 및 피부 노화를 방지하는 물질을 스크리닝하는 방법
JP5658696B2 (ja) * 2011-02-25 2015-01-28 株式会社ファンケル 皮膚のストレス蓄積度の評価方法
JP5542110B2 (ja) * 2011-11-21 2014-07-09 株式会社ファンケル 皮膚色素沈着マーカーとその利用技術
KR102027451B1 (ko) 2012-11-02 2019-10-02 (주)아모레퍼시픽 마이크로 rna 및 이를 사용하는 스크리닝 방법
JP6182728B2 (ja) * 2012-11-02 2017-08-23 国立大学法人名古屋大学 幹細胞を標的とした薬効及び毒性の評価法
CN103808940B (zh) * 2012-11-02 2017-06-06 株式会社芳珂 粗糙肌肤的评价方法
JP6609401B2 (ja) * 2014-06-16 2019-11-20 株式会社ファンケル カリクレイン7産生促進剤
JP6530646B2 (ja) * 2015-06-22 2019-06-12 株式会社ファンケル 頭皮の圧縮応力の評価方法
JP6531906B2 (ja) * 2015-07-08 2019-06-19 国立大学法人 熊本大学 皮膚状態の評価方法
JP6993076B2 (ja) * 2015-12-24 2022-01-13 ポーラ化成工業株式会社 皮下組織構造の改善成分のスクリーニング方法
KR20170076484A (ko) 2015-12-24 2017-07-04 삼성전자주식회사 프로토카데린의 과발현을 이용한 노화 세포를 분리하는 방법
KR101971358B1 (ko) * 2016-09-26 2019-04-23 동국대학교 산학협력단 검버섯 진단용 마커로서의 구아닌 탈아미노효소의 용도
US20210109111A1 (en) * 2016-11-25 2021-04-15 Université Grenoble Alpes New biomarkers of human skin aging
CN106906180A (zh) 2016-12-28 2017-06-30 里程 一种具有生物活化作用的复合添加剂及其制备方法和用途
JP6923111B2 (ja) * 2017-02-27 2021-08-18 ポーラ化成工業株式会社 皮膚老化改善剤のスクリーニング方法
JP7445288B2 (ja) * 2017-08-01 2024-03-07 Karydo TherapeutiX株式会社 皮膚のバイオマーカー
CN109839507A (zh) * 2017-11-27 2019-06-04 江苏坤辉生物科技有限公司 一种检测紫外光损伤的生物标志物及其应用
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
US20190369119A1 (en) * 2018-06-04 2019-12-05 Avon Products, Inc. Protein Biomarkers for Identifying and Treating Aging Skin and Skin Conditions
WO2020116606A1 (ja) * 2018-12-06 2020-06-11 キリンホールディングス株式会社 T細胞又はnk細胞の製造方法、t細胞又はnk細胞の培養用培地、t細胞又はnk細胞の培養方法、未分化t細胞の未分化状態を維持する方法及びt細胞又はnk細胞の増殖促進剤
EP3948290A4 (en) 2019-03-26 2023-08-09 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES FOR SKIN CANCERS
WO2021036807A1 (zh) * 2019-08-26 2021-03-04 中国科学院上海营养与健康研究所 一类小rna分子及其类似物在抗衰老中的应用
WO2024085637A1 (ko) * 2022-10-18 2024-04-25 동국대학교 산학협력단 혈장 유래 단백질을 포함하는 노화 방지용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197602A1 (en) * 1998-04-15 2002-12-26 Glenna C. Burmer Nucleic acid sequences and proteins associated with aging
JP2001212087A (ja) 2000-01-31 2001-08-07 Axiom Co Ltd 肌年齢算出装置および肌年齢算出方法
JP4413387B2 (ja) * 2000-07-12 2010-02-10 丸善製薬株式会社 コラーゲン産生促進剤、エラスターゼ活性阻害剤、コラゲナーゼ活性阻害剤及び皮膚化粧料
JP2002277455A (ja) * 2001-03-15 2002-09-25 Shiseido Co Ltd 皮膚老化因子検出組成物及び検出方法
WO2002074911A2 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
JP4575619B2 (ja) 2001-05-08 2010-11-04 ポーラ化成工業株式会社 実年齢の推定方法
JP4681760B2 (ja) 2001-06-06 2011-05-11 ポーラ化成工業株式会社 顔形状の加齢変化の推定法
US20030026794A1 (en) * 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
JP3863462B2 (ja) * 2002-06-24 2006-12-27 株式会社資生堂 皮膚疾患および敏感肌の検査方法ならびにその方法に利用するキット
KR20050039828A (ko) * 2002-07-03 2005-04-29 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 종양 노쇠 유전자의 발현을 확인하고 조절하기 위한 시약및 방법
KR101318521B1 (ko) * 2005-08-23 2013-10-16 가오루 미야자키 피부 노화 마커와 그의 이용기술

Also Published As

Publication number Publication date
US20090305242A1 (en) 2009-12-10
JPWO2007023808A1 (ja) 2009-02-26
KR101318521B1 (ko) 2013-10-16
WO2007023808A1 (ja) 2007-03-01
CN101248192B (zh) 2013-02-20
JP5596742B2 (ja) 2014-09-24
JP5362219B2 (ja) 2013-12-11
JP2012189602A (ja) 2012-10-04
JP2014149299A (ja) 2014-08-21
CN101248192A (zh) 2008-08-20
US7972788B2 (en) 2011-07-05
JP2013174608A (ja) 2013-09-05
KR20080057233A (ko) 2008-06-24
JP5663054B2 (ja) 2015-02-04

Similar Documents

Publication Publication Date Title
HK1114883A1 (en) Skin aging marker and technique for use thereof
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
CR20110470A (es) Proteínas de union a il-17
ATE450547T1 (de) Eml4-alk-fusionsgen
EP3101141A3 (en) Method for methylation analysis
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
EP1687283A4 (en) PROCESS AND COMPOSITION FOR DETERMINING FK 506
BRPI0812875B8 (pt) " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste
WO2012067970A3 (en) Transcriptional repression leading to parkinson's disease
WO2005064307A3 (en) Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
WO2006113477A3 (en) Use of phosphonazo iii for the measurement of calcium, magnesium and sodium in analytical samples
GB201014837D0 (en) Biomarker signatures and uses thereof
EP3425394A4 (en) KIT FOR DETERMINING THE GALLENIC ACID IN A BIOLOGICAL SAMPLE AND METHOD FOR DETERMINING THE GALLENIC ACID QUANTITY IN THE BIOLOGICAL SAMPLE
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
MX2009004852A (es) Procedimiento para la determinacion de la fragmentacion del adn en microorganismos.
EP1769244A4 (en) DETECTION OR MEASUREMENT OF ANTIGEN PROTEIN ANTIBODIES IN BIOLOGICAL TISSUE OR SAMPLES
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
HK1112928A1 (en) Cspcna isoform modifications and uses thereof
EP1953541A4 (en) METHOD FOR DETERMINING DOUBLE-STRANDED DNA QUANTITY AND DETERMINING KIT
WO2010000467A8 (en) Asc as a marker for lung cancer
WO2009094556A3 (en) Identification of predictive markers of response to dasatinib in human colon cancer
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
EP2540839A4 (en) METHOD FOR DETERMINING THE PRESENCE OR REDUCTION OF CANCER CELLS IN A BIOLOGICAL SAMPLE AND MOLECULAR MARKERS AND KIT THEREFOR
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
HK1130903A1 (en) Method of evaluating skin sensitivity level by using squamous cell carcinoma-related antigen as indication